May 06, 2026
Novo Nordisk (NVO) Stock Jumps After Q1 Earnings Crush Estimates on Oral Wegovy Success
Novo Nordisk (NVO) shares climb after Q1 earnings beat estimates with $15.17B revenue. Oral Wegovy pill crosses 2M prescriptions, boosting 2026 outlook.
The post Novo Nordisk (NVO) Stock Jumps After Q1 Earnings Crush Estimates on Oral Wegovy Success appeared first on Blockonomi.
Source: Blockonomi →Related News
- 22 hours ago
Hewlett Packard Enterprise (HPE) Stock Soars to Record Peak as Elliott Expands P...
- 22 hours ago
Norwegian Cruise Line (NCLH) Stock Plummets 9.5% — Company Insiders Buy Big
- 22 hours ago
Dell (DELL) Stock Rockets 16% to All-Time Peak Ahead of May 28 Earnings
- 22 hours ago
BlackBerry (BB) Stock Surges 19% to New 52-Week Peak on Bullish Outlook
- 22 hours ago
Navitas Semiconductor (NVTS) Stock Soars 20% as AI Power Shift Fuels Rally